GlobeNewswire Inc.··NaApogee Therapeutics Raises $350M via Public Offering to Fuel Biotech Pipeline
Apogee Therapeutics prices $350M offering at $70/share to fund development of inflammatory disease treatments, with lead candidate Zumilokibart targeting atopic dermatitis.
APGEclinical-stagepublic offering